NACDS Anti-Counterfeit Proposal Would Use “One Forward/One Back” Model
Executive Summary
FDA should require distributors to adopt a "one forward/one back" record keeping system for drug sales to prevent counterfeiting, the National Association of Chain Drug Stores recommended
You may also be interested in...
FDA Anti-Counterfeiting Focus Should Be Wholesaler Licensing, PDA Says
FDA and states should tighten drug wholesaler licensing requirements in a way that does not "unduly restrict the interstate business of wholesaling" by licensed companies, the Pharmaceutical Distributors Association says
Anti-Counterfeiting Interim Step Should Be Paper Pedigree, PhRMA Says
Drug products should contain paper pedigrees as an interim anti-counterfeit measure, the Pharmaceutical Research & Manufacturers of America said at FDA's Oct. 15 Anti-Counterfeit Drug Initiative public meeting in Bethesda, Md
FDA Counterfeit Report Seeks “Electronic Pedigree” To Aid Drug Tracking
The pharmaceutical industry's long-term goal in counterfeit prevention should be to have all drug products contain an "electronic pedigree," FDA's Counterfeit Drug Task Force interim report says